Background. While dopamine produces well-characterized dose-dependent effec
ts on systemic hemodynamics, there is a paucity of information regarding it
s effects on hepatic hemodynamics, Infusion rates above 10 mu g/kg/min are
reported to produce significant vasoconstriction and impair organ perfusion
. Therefore, donors are sometimes considered unsuitable when higher doses o
f dopamine are in use. The aim of this study was to determine the effect of
increasing doses of dopamine on hepatic hemodynamics in a nonanesthetized
swine model.
Materials and methods. Sixteen pigs were instrumented with indwelling cathe
ters in a peripheral artery, peripheral vein, portal vein, and hepatic vein
and flow probes around the portal vein and hepatic artery. After recovery,
the following variables were measured 10 +/- 1 days postinstrumentation: h
epatic arterial flow (HAF), portal venous flow (PVF), mean systemic arteria
l pressure (MAP), central venous pressure (CVP), portal venous pressure (PV
P), hepatic venous pressure (HVP), heart rate (HR). Recordings were obtaine
d at baseline and subsequently when dopamine was infused at rates of 3, 6,
12, 15, 21, and 30 mu g/kg/min increasing at l-h intervals.
Results. HAF and PVF increased linearly over the entire infusion range, to
69 and 13% over baseline, respectively (P < 0.001, P < 0.05). Total hepatic
blood flow rose 23% over baseline at the 30 mu g/kg/min dosage (P < 0.01).
MAP increased linearly 13% over the range 12 to 30 mu g/kg/min (P < 0.001)
. CVP, HVP, and PVP did not change significantly. HR decreased from 12 to 1
5 mu g/kg/min (P < 0.01), then increased from 15 to 30 mu g/kg/min (P < 0.0
5).
Conclusion. These data show that dopamine infused at dosages of 3-30 mu g/k
g/min augments HAF, PVF, and THBF and that this effect is linear. These res
ults suggest high-dose dopamine infusion does not disqualify a potential do
nor liver for transplantation. (C) 2000 Academic Press.